Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Machens

Showing results (31-40 of 157) with videos related to

Pageof 16
Sort By:
Annals of Surgical Oncology|June 1, 2011
Simultaneous medullary and papillary thyroid cancer: a novel entity?Andreas Machens, Henning Dralle
Molecular and Cellular Endocrinology|December 14, 2005
Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedsideAndreas Machens, Henning Dralle
Clinical Endocrinology|February 27, 2010
Peak calcitonin cut-off levels for the diagnosis of occult medullary thyroid cancer: evidence of confounding by genderAndreas Machens, Henning Dralle
Clinical Endocrinology|May 23, 2006
Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomasAndreas Machens, Henning Dralle
World Journal of Surgery|April 25, 2007
Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinomaAndreas Machens, Henning Dralle
Annals of Surgical Oncology|November 5, 2008
Prediction of mediastinal lymph node metastasis in papillary thyroid cancerAndreas Machens, Henning Dralle
Clinics (Sao Paulo, Brazil)|May 16, 2012
Multiple endocrine neoplasia type 2: achievements and current challengesAndreas Machens, Henning Dralle
Endocrine Journal|May 23, 2009
Parathyroid gland preservation in situ versus total parathyroidectomy with autotransplantation in patients at risk of MEN2AAndreas Machens, Henning Dralle
The New England Journal of Medicine|September 25, 2007
Adjuvant mitotane in adrenocortical carcinomaAndreas Machens, Henning Dralle
Best Practice & Research. Clinical Endocrinology & Metabolism|May 3, 2019
Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancerAndreas Machens, Henning Dralle
Pageof 16

Showing results (31-40 of 157) with videos related to

Sort By:
Pageof 16
Annals of Surgical Oncology|June 1, 2011
Simultaneous medullary and papillary thyroid cancer: a novel entity?Andreas Machens, Henning Dralle
Molecular and Cellular Endocrinology|December 14, 2005
Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedsideAndreas Machens, Henning Dralle
Clinical Endocrinology|February 27, 2010
Peak calcitonin cut-off levels for the diagnosis of occult medullary thyroid cancer: evidence of confounding by genderAndreas Machens, Henning Dralle
Clinical Endocrinology|May 23, 2006
Association of HLA DQ4-DR8 haplotype with papillary thyroid carcinomasAndreas Machens, Henning Dralle
World Journal of Surgery|April 25, 2007
Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinomaAndreas Machens, Henning Dralle
Annals of Surgical Oncology|November 5, 2008
Prediction of mediastinal lymph node metastasis in papillary thyroid cancerAndreas Machens, Henning Dralle
Clinics (Sao Paulo, Brazil)|May 16, 2012
Multiple endocrine neoplasia type 2: achievements and current challengesAndreas Machens, Henning Dralle
Endocrine Journal|May 23, 2009
Parathyroid gland preservation in situ versus total parathyroidectomy with autotransplantation in patients at risk of MEN2AAndreas Machens, Henning Dralle
The New England Journal of Medicine|September 25, 2007
Adjuvant mitotane in adrenocortical carcinomaAndreas Machens, Henning Dralle
Best Practice & Research. Clinical Endocrinology & Metabolism|May 3, 2019
Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancerAndreas Machens, Henning Dralle
Pageof 16